Mesenchymal stem cells treatment for ischemic stroke: an update on animal studies
Mesenchymal stem cells (MSCs) have great potential in the treatment of ischemic stroke. Because they possess low immunogenicity, high proliferation, and different capabilities. MSCs are mostly derived from bone marrow, adipose tissue, and placenta; they act mainly by regulating immune and inflammato...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Tianjin Huanhu Hospital
2023-04-01
|
| Series: | Chinese Journal of Contemporary Neurology and Neurosurgery |
| Subjects: | |
| Online Access: | http://www.cjcnn.org/index.php/cjcnn/editor/submission/2673 |